Dublin, July 08, 2021 (GLOBE NEWSWIRE) -- The "Sterile Vials Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
The report on the global sterile vials market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2021 to 2031. The report provides the overall revenue of the global sterile vials market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global sterile vials market for the forecast period of 2021-2031.
The report has been prepared after extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the sterile vials market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomena in the global sterile vials market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the sterile vials market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global sterile vials market.
The report delves into the competitive landscape of the global sterile vials market. Key players operating in the sterile vials market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the sterile vials market profiled in this report.
Key Questions Answered in the Report
- How does the development of sterile vials provide scope of growth of the global sterile vials market?
- How alliances and partnerships between players are widening the scope of new line of technologies for sterile vials?
- What are the revenue share projections of key segments under various criteria in the sterile vials market during the forecast period?
- Which segment is likely to register leading revenue until the end of the forecast period in 2031?
Key Topics Covered:
1. Preface
2. Assumptions and Research Methodology
3. Executive Summary: Global Sterile Vials Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Trends
4.4. Global Sterile Vials Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
5. Key Insights
5.1. Recent Development (industry updates, merger & acquisitions)
5.2. Key Vendor and Distributor Analysis
5.3. Sterile Vials Pricing Analysis
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Sterile Vials Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value and Volume Forecast by Product, 2017-2031
6.3.1. Sterile Empty Vial
6.3.1.1. Sterile Evacuated Vial
6.3.1.2. Sterile Nitrogen Filled Vial
6.3.1.3. Sterile Air Filled Vial
6.3.2. Sterile Liquid Filled Vial
6.3.2.1. Sterile Saline Filled Vial
6.3.2.2. Sterile Media Filled Vial
6.3.2.3. Sterile Water Filled Vial
6.3.3. Individual Sterilized Components (ISCs)
6.4. Market Attractiveness Analysis, by Product
7. Global Sterile Vials Market Analysis and Forecast, by Volume
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value and Volume Forecast, by Volume, 2017-2031
7.3.1. < 2ml
7.3.2. 2 ml to 5ml
7.3.3. 5 ml to 10 ml
7.3.4. 10 ml to 20 ml
7.3.5. >20ml
7.4. Market Attractiveness Analysis, by Volume
8. Global Sterile Vials Market Analysis and Forecast, by Material
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value & Volume Forecast, by Material, 2017-2031
8.3.1. Glass
8.3.2. Plastic
8.4. Market Attractiveness Analysis, by Material
9. Global Sterile Vials Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value and Volume Forecast, by End-user, 2017-2031
9.3.1. Clinical Labs
9.3.2. Compounding Labs
9.3.3. Biopharmaceutical Companies
9.3.4. CMOs
9.3.5. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Sterile Vials Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value and Volume Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Sterile Vials Market Analysis and Forecast
12. Europe Sterile Vials Market Analysis and Forecast
13. Asia Pacific Sterile Vials Market Analysis and Forecast
14. Latin America Sterile Vials Market Analysis and Forecast
15. Middle East & Africa Sterile Vials Market Analysis and Forecast
16. Competitive Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Company Profiles
16.2.1. Adelphi Healthcare Packaging (The Adelphi Group Of Companies)
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Strategic Overview
16.2.1.5. SWOT Analysis
16.2.2. APG Europe
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Strategic Overview
16.2.2.5. SWOT Analysis
16.2.3. Bormioli Pharma S.p.a.
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Strategic Overview
16.2.3.5. SWOT Analysis
16.2.4. Corning Incorporated
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Strategic Overview
16.2.4.5. SWOT Analysis
16.2.5. Dalton Pharma Services
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Strategic Overview
16.2.5.5. SWOT Analysis
16.2.6. DWK Life Sciences GmbH
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Strategic Overview
16.2.6.5. SWOT Analysis
16.2.7. Gerresheimer AG
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Strategic Overview
16.2.7.5. SWOT Analysis
16.2.8. Nipro Corporation
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Strategic Overview
16.2.8.5. SWOT Analysis
16.2.9. O.Berk Company
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. Strategic Overview
16.2.9.5. SWOT Analysis
16.2.10. Pacific Vial
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Financial Overview
16.2.10.3. Product Portfolio
16.2.10.4. Strategic Overview
16.2.10.5. SWOT Analysis
16.2.11. Piramal Glass (Piramal Enterprises Ltd.)
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Financial Overview
16.2.11.3. Product Portfolio
16.2.11.4. Strategic Overview
16.2.11.5. SWOT Analysis
16.2.12. Schott AG
16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.12.2. Financial Overview
16.2.12.3. Product Portfolio
16.2.12.4. Strategic Overview
16.2.12.5. SWOT Analysis
16.2.13. SDG Pharma
16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.13.2. Financial Overview
16.2.13.3. Product Portfolio
16.2.13.4. Strategic Overview
16.2.13.5. SWOT Analysis
16.2.14. Shandong Pharmaceutical Glass Co. Ltd.
16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.14.2. Financial Overview
16.2.14.3. Product Portfolio
16.2.14.4. Strategic Overview
16.2.14.5. SWOT Analysis
16.2.15. SiO2 Materials Science
16.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.15.2. Financial Overview
16.2.15.3. Product Portfolio
16.2.15.4. Strategic Overview
16.2.15.5. SWOT Analysis
16.2.16. Stevanato Group
16.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.16.2. Financial Overview
16.2.16.3. Product Portfolio
16.2.16.4. Strategic Overview
16.2.16.5. SWOT Analysis
16.2.17. Thermo Fisher Scientific, Inc.
16.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.17.2. Financial Overview
16.2.17.3. Product Portfolio
16.2.17.4. Strategic Overview
16.2.17.5. SWOT Analysis
16.2.18. West Pharmaceutical Services, Inc.
16.2.18.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.18.2. Financial Overview
16.2.18.3. Product Portfolio
16.2.18.4. Strategic Overview
16.2.18.5. SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/r/y9kgbc